• DocumentCode
    2177193
  • Title

    Drug Design for AMP-Activated Protein Kinase Agonists in Silico

  • Author

    Chen, Chien-Yu ; Bau, Da-Tian ; Tsai, Ming-Hsui ; Hsu, Yuan-Man ; Ho, Tin-Yun ; Huang, Hung-Jin ; Chang, Yea-Huey ; Tsai, Fuu-Jen ; Tsai, Chang-Hai ; Chen, Calvin Yu-Chian

  • Author_Institution
    Dept. of Biol. Sci. & Technol., China Med. Univ., Taichung, Taiwan
  • fYear
    2009
  • fDate
    17-19 Oct. 2009
  • Firstpage
    1
  • Lastpage
    4
  • Abstract
    AMP-activated protein kinase (AMPK) is a metabolite- sensed protein kinase in various eukaryotes. The activated AMPK regulates important proteins which cause diabetes, obesity, metabolic aberrant, and also breast cancer. In this study, the yeast AMPK structure was used as a template to model the human AMPK structure. By homology modeling, the reliable AMPK structure was built, and the active binding site was defined corresponding to X-ray crystal structure of yeast AMPK By virtual screening the database. All the potent ligands had the H-bond interaction in the key residues, same as the control. Thus, we suggested the phenylamide derivates might be the potent AMPK agonists.
  • Keywords
    diseases; drugs; enzymes; molecular biophysics; molecular configurations; AMP-activated protein kinase agonists; H-bond interaction; X-ray crystal structure; breast cancer; diabetes; drug design; homology modeling; human AMPK structure; metabolic aberrant; metabolite-sensed protein kinase; obesity; phenylamide derivates; potent ligands; silico; virtual screening; yeast AMPK structure; Amino acids; Asia; Diabetes; Drugs; Fungi; Hospitals; Humans; Laboratories; Proteins; Sugar;
  • fLanguage
    English
  • Publisher
    ieee
  • Conference_Titel
    Biomedical Engineering and Informatics, 2009. BMEI '09. 2nd International Conference on
  • Conference_Location
    Tianjin
  • Print_ISBN
    978-1-4244-4132-7
  • Electronic_ISBN
    978-1-4244-4134-1
  • Type

    conf

  • DOI
    10.1109/BMEI.2009.5304901
  • Filename
    5304901